Carcinoid tumors, a subtype of neuroendocrine neoplasms, present unique challenges in diagnosis and treatment. These slow-growing tumors can originate in various areas of the gastrointestinal (GI) tract, including the foregut, midgut, and hindgut. Located throughout Long Island, our practice provides comprehensive digestive health care services to individuals in Queens, Levittown, and surrounding areas, focusing on effective management and innovative treatment options for carcinoid tumors. Our lead gastroenterologist, Dr. Mit Shah, MD, is board-certified and has over a decade of experience in gastroenterology, ensuring we provide top-quality care for our patients.
I had a pleasant experience at this office. Dr. Shah was very professional, kind and knowledgeable. The office is very clean and welcoming. The staff is friendly and make you feel relaxed. Very easy to schedule procedures and the wait time is very short. I highly recommend them.
Carcinoid Tumors Diagnosis and Symptoms in Long Island
Diagnosing carcinoid tumors can be complex due to their often asymptomatic nature in early stages. Common symptoms may include abdominal pain, changes in bowel habits, and possibly flushing or other symptoms associated with carcinoid syndrome. Utilizing advanced imaging studies and biomarkers, including serotonin levels and 5-HIAA, our experienced team in Long Island is well-equipped to accurately identify these tumors and discuss prognosis and treatment options with our patients.
Explore Treatment Options for Carcinoid Tumors
Treatment strategies for carcinoid tumors vary based on tumor location, size, and presence of metastasis. Surgical resection is a primary treatment option for localized carcinoid tumors, offering the potential for a cure in select cases. For non-resectable cases, our practice explores other avenues such as:
- Debulking surgery to alleviate symptoms
- Administration of somatostatin analogues, such as octreotide, to control hormone secretion and reduce symptoms of carcinoid syndrome
- Chemotherapy for systemic disease management
- Interventional procedures like hepatic artery embolization and Peptide Receptor Radionuclide Therapy (PRRT) to treat advanced tumors
These treatment options are tailored to meet the specific needs of our patients across Long Island.
How Our Practice Supports Carcinoid Tumor Management
At our practice, we recognize that managing carcinoid tumors requires a multidisciplinary approach. Led by board-certified gastroenterologists, Dr. Mit Shah and Dr. Davinder Singh, both of whom have extensive training in gastroenterology, we provide personalized treatment plans. Dr. Singh, who previously served as an assistant professor at the Mayo Clinic, integrates cutting-edge practices into our care protocols. Our team remains committed to educating patients about their condition and engaging them in their health management strategies.
Why Early Detection Matters for Carcinoid Tumors
Early detection of carcinoid tumors is crucial for effective management. Recognizing the symptoms and seeking medical attention promptly can lead to a more favorable outcome. Our practice emphasizes the importance of annual screenings and thorough evaluations, especially for patients presenting with risk factors for GI cancers.
Surgical Approaches to Carcinoid Tumors Care
In cases where surgical intervention is appropriate, our practice is dedicated to providing state-of-the-art surgical techniques, ensuring the best possible outcomes through minimally invasive procedures when applicable. Our board-certified surgeons employ their vast expertise to manage carcinoid tumor cases effectively, contributing to enhanced recovery experiences for our patients.
Understanding Treatment with Somatostatin Analogues
Somatostatin analogues play a vital role in the management of carcinoid tumors, particularly for those exhibiting hormone-secreting behavior. These medications help in reducing symptoms and slowing tumor growth. Our specialists are skilled in integrating this treatment into personalized care protocols, guiding patients on the effective use of these medications.
FAQ About Carcinoid Tumors with Our Practice
-
Carcinoid tumors are slow-growing neoplasms that primarily occur in the gastrointestinal tract. They are a subset of neuroendocrine tumors that can lead to various symptoms based on hormone secretion and tumor location.
-
Diagnosis typically involves a combination of imaging studies, biopsies, and blood tests measuring biomarkers such as serotonin and 5-HIAA levels.
-
Treatment options may include surgical excision, debulking surgery, somatostatin analogues, chemotherapy, and other interventional techniques depending on each patient’s specific situation.
-
Early detection allows for timely intervention, which can lead to better management outcomes and improve the overall quality of life for patients.
-
Somatostatin analogues help control symptoms related to hormone secretion and can slow tumor progression, making them an essential component of the treatment strategy for carcinoid tumors.
Why Choose Comprehensive Digestive Health Care
Choosing our practice for carcinoid tumor management means partnering with a team that values evidence-based care. With over a decade of combined experience in gastroenterology, Dr. Shah and Dr. Singh are devoted to providing specialized treatment options tailored to meet your needs in Queens and Levittown. Our practice is also committed to continuous education, research, and implementing innovative practices in digestive health care. Contact our award-winning team today to schedule a consultation.
About UsGet Started on Your Health Journey Today
For residents seeking comprehensive evaluation and treatment for carcinoid tumors in Long Island, our practice is here to help. With our dedication to advanced gastroenterology and patient-centered care, you can rely on our experienced team to support you every step of the way. Schedule your consultation with our team today to discuss your health needs and explore the best treatment options available for you.
